TW
ABBV icon

Trajan Wealth’s AbbVie ABBV Stock Holding History

Trajan Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45M Buy
37,545
+9,979
+36% +$2.15M 0.36% 61
2026
Q1 		$6M Buy
27,566
+2,515
+10% +$558K 0.24% 77
2025
Q4 		$5.72M Sell
25,051
-8
-0% -$1.82K 0.24% 70
2025
Q3 		$5.8M Buy
25,059
+473
+2% +$96.3K 0.25% 69
2025
Q2 		$4.56M Buy
24,586
+791
+3% +$147K 0.22% 86
2025
Q1 		$4.99M Sell
23,795
-6,717
-22% -$1.31M 0.27% 78
2024
Q4 		$5.42M Buy
30,512
+1,702
+6% +$313K 0.3% 64
2024
Q3 		$5.69M Sell
28,810
-439
-2% -$81.9K 0.34% 64
2024
Q2 		$5.02M Buy
29,249
+3,384
+13% +$561K 0.32% 62
2024
Q1 		$4.71M Buy
+25,865
New +$4.46M 0.32% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trajan Wealth's ABBV Position: Q2 2026 in Review

Trajan Wealth increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $2.15M and bringing the position to 37,545 shares worth $9.45M. The position accounts for 0.36% of the portfolio, ranked #61.

Trajan Wealth first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trajan Wealth held 37,545 shares of AbbVie worth $9.45M as of Q2 2026.
  • Trajan Wealth bought 9,979 AbbVie shares in Q2 2026, an estimated $2.15M.
  • AbbVie made up 0.36% of Trajan Wealth's portfolio in Q2 2026, its #61 holding.
  • Trajan Wealth first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trajan Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.